LAMON KIM DAVID 4
4 · ICN PHARMACEUTICALS INC · Filed Nov 6, 2003
Insider Transaction Report
Form 4
LAMON KIM DAVID
Pres. & Chief Scientific Off.
Transactions
- Award
Incentive Stock Option (right to buy)
2003-11-04+21,560→ 21,560 totalExercise: $18.55From: 2004-11-04Exp: 2013-11-04→ Common Stock (21,560 underlying) - Award
Non-Qualified Stock Option (right to buy)
2003-11-04+125,440→ 125,440 totalExercise: $18.55From: 2004-11-04Exp: 2013-11-04→ Common Stock (125,440 underlying)